(PRWEB) May 11, 2017
VTI – Vertebral Technologies, Inc. a MIS focused medical device company based in Minneapolis, MN, has received notice of allowance for its patent: Methods and Apparatus for Minimally Invasive Modular Interbody Fusion Devices. This grant expands and extends VTI’s suite of patents covering its unique modular device design.
VTI has 28 patents and patent pending assets in its global intellectual property portfolio.
“We are excited about the grant of this patent. VTI’s global intellectual property suite is extensive and provides a strong base of protections for our continued expansion.” commented Matthew R Kyle, President & CEO of VTI.
ABOUT VTI’S INTERFUSE® SPINAL FUSION SYSTEM
VTI’s InterFuse® System is an intra-operative assembly technology, which allows surgeons to implant a large footprint device through a minimally invasive approach. The shape of each device is biomechanically optimized to match the contours of the endplate and the unique anatomical shape and size of each patient’s disc space. Learn more about VTI’s InterFuse product here: http://www.vti-spine.com/product/interfuse/
ABOUT VTI - VERTEBRAL TECHNOLOGIES, INC.
VTI - Vertebral Technologies, Inc. is a privately held company based in Minneapolis, MN, USA. VTI is dedicated to the design, development, manufacturing and marketing of medical devices to address painful conditions of the spine through less-invasive surgical approaches. VTI’s products utilize its unique modular-assembly technology to deliver solutions optimized for both surgeons and their patients. VTI sells its InterFuse® modular interbody fusion devices worldwide. Learn more about VTI here: http://www.vti-spine.com/
For more information, visit: http://www.vti-spine.com or contact Brian Thron at marketing(at)vti-spine(dot)com or + 1.877.912.5401.